- Home
- SCS vs ALVO Comparison
SCS vs ALVO Comparison
Compare SCS & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SCS | ALVO |
|---|---|---|
| Founded | 1912 | 2013 |
| Country | United States | Luxembourg |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | SCS | ALVO |
|---|---|---|
| Price | $16.24 | $4.78 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $10.67 |
| AVG Volume (30 Days) | ★ 1.4M | 592.2K |
| Earning Date | 12-17-2025 | 11-12-2025 |
| Dividend Yield | ★ 2.44% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.81 | 0.24 |
| Revenue | ★ $3,259,000,000.00 | $573,350,000.00 |
| Revenue This Year | $5.09 | $34.94 |
| Revenue Next Year | $2.83 | $39.55 |
| P/E Ratio | $20.29 | ★ $19.36 |
| Revenue Growth | 3.92 | ★ 45.55 |
| 52 Week Low | $9.32 | $4.32 |
| 52 Week High | $17.40 | $13.70 |
Technical Indicators
Market Signals| Indicator | SCS | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 54.39 | 34.65 |
| Support Level | $15.45 | $4.32 |
| Resistance Level | $16.52 | $5.49 |
| Average True Range (ATR) | 0.24 | 0.26 |
| MACD | 0.07 | 0.05 |
| Stochastic Oscillator | 74.18 | 38.96 |
Price Performance
Historical ComparisonAbout SCS Steelcase Inc.
Steelcase Inc is a furniture company based in the United States. Its brands, such as Steelcase, AMQ, Coalesse, Designtex, and others, offer a portfolio of furniture and architectural products and services designed to help customers create workplaces. It markets its products and services to businesses and organizations predominantly through a network of dealers and also sells to consumers in markets around the world through web-based and retail distribution channels. The company's reportable segments include the Americas, which generates key revenue, and the International segment.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.